Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Preclinical rationale and phase I clinical trial of the adriamycin analog, AD 32.

Preclinical rationale and phase I clinical trial of the adriamycin analog, AD 32. Recent Results Cancer Res. 1981; 76:7-15.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.